TELA Bio, Inc. financial data

Symbol
TELA on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
1 Great Valley Parkway, Suite 24, Malvern, PA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 429 % -15.4%
Quick Ratio 87.2 % -9.65%
Debt-to-equity 346 % +27.1%
Return On Equity -253 % -17.2%
Return On Assets -56.6 % +2.19%
Operating Margin -60 % +27.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 24.7M shares +0.92%
Common Stock, Shares, Outstanding 24.7M shares +0.82%
Entity Public Float 245M USD +351%
Common Stock, Value, Issued 25K USD +4.17%
Weighted Average Number of Shares Outstanding, Basic 24.7M shares +6.13%
Weighted Average Number of Shares Outstanding, Diluted 24.7M shares +6.13%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 64.7M USD +31.6%
Research and Development Expense 9.77M USD +3.99%
Selling and Marketing Expense 65.9M USD +29.5%
General and Administrative Expense 15.2M USD +9.73%
Operating Income (Loss) -38.9M USD +4.16%
Nonoperating Income (Expense) -3.25M USD -9.6%
Net Income (Loss) Attributable to Parent -42.1M USD +3.22%
Earnings Per Share, Basic -1.69 USD/shares +22.5%
Earnings Per Share, Diluted -1.69 USD/shares +22.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 26.5M USD -59.4%
Inventory, Net 13.4M USD -5.15%
Assets, Current 51.1M USD -42.7%
Property, Plant and Equipment, Net 2.35M USD +33.2%
Operating Lease, Right-of-Use Asset 1.85M USD +61.7%
Intangible Assets, Net (Excluding Goodwill) 1.93M USD -16.5%
Other Assets, Noncurrent 2.7M USD
Assets 60.2M USD -36.2%
Accounts Payable, Current 2.31M USD +2.84%
Employee-related Liabilities, Current 6.61M USD +6%
Accrued Liabilities, Current 12.7M USD +17.4%
Liabilities, Current 15M USD +14.9%
Operating Lease, Liability, Noncurrent 1.7M USD +41.7%
Other Liabilities, Noncurrent 1.53M USD +35.9%
Liabilities 57.3M USD +5.43%
Accumulated Other Comprehensive Income (Loss), Net of Tax 98K USD +16.7%
Retained Earnings (Accumulated Deficit) -339M USD -14.2%
Stockholders' Equity Attributable to Parent 2.87M USD -92.8%
Liabilities and Equity 60.2M USD -36.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -14.4M USD -24.3%
Net Cash Provided by (Used in) Financing Activities 56K USD
Net Cash Provided by (Used in) Investing Activities 4.7M USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 24.7M shares +0.82%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -9.59M USD +19.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 26.8M USD -59%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.18M USD +7.46%
Deferred Tax Assets, Valuation Allowance 71.1M USD +18.2%
Deferred Tax Assets, Gross 72M USD +18.2%
Operating Lease, Liability 2.25M USD +43.2%
Depreciation 139K USD +15.8%
Payments to Acquire Property, Plant, and Equipment 304K USD +164%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -42.1M USD +3.35%
Lessee, Operating Lease, Liability, to be Paid 3.74M USD +83.2%
Property, Plant and Equipment, Gross 6.32M USD +8.54%
Operating Lease, Liability, Current 571K USD +66.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 580K USD +58.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 601K USD +67.9%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.49M USD +218%
Lessee, Operating Lease, Liability, to be Paid, Year Three 557K USD +48.5%
Deferred Tax Assets, Operating Loss Carryforwards 61.4M USD +11.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 570K USD +48.8%
Operating Lease, Payments 400K USD +33.3%
Additional Paid in Capital 342M USD +1.47%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 4.8M USD +7%
Interest Expense 5.31M USD +21%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%